| Literature DB >> 32292435 |
Saira Jafri1, Naseem Ahmed2, Nausheen Saifullah3, Mehak Musheer4.
Abstract
OBJECTIVE: The literature on interstitial lung diseases is limited. The aim of this research was to make this entity of diseases more understandable to clinicians and general population of the region of Pakistan.Entities:
Keywords: Connective Tissue Disease (CTD); Interstitial lung disease (ILD); gastro-esophageal reflux disease (GERD); idiopathic pulmonary fibrosis (IPF); non-specific interstitial pneumonitis (NSIP); usual interstitial pneumonitis (UIP)
Year: 2020 PMID: 32292435 PMCID: PMC7150376 DOI: 10.12669/pjms.36.3.1046
Source DB: PubMed Journal: Pak J Med Sci ISSN: 1681-715X Impact factor: 1.088
Fig.1Distribution ILD subtypes.
Contributory factor analysis of ILDs.
| IPF (n = 95) | Others (n=150) | Odd ratio (95% CI) | P-value | |
|---|---|---|---|---|
| • Male | 31 (32.6) | 45 | 1.47 (0.84-2.57) | 0.179 |
| • Female | 54 (67.4) | 115 | ||
| Dyspnea | 92 (96.8) | 141 (94.0) | 1.96 (0.52-7.42) | 0.315 |
| Cough | 85 (89.5) | 126 (84.0) | 1.62 (0.74-3.56) | 0.227 |
| Phlegm | 25 (26.3) | 34 (22.7) | 1.22 (0.67-2.21) | 0.515 |
| Postnasal drip | 19 (20.0) | 36 (24.0) | 0.79 (0.42-1.48) | 0.465 |
| Weight loss | 53 (55.8) | 76 (50.7) | 1.23 (0.73-2.06) | 0.434 |
| Dysphagea | 17 (17.9) | 25 (16.7) | 1.09 (0.55-2.15) | 0.804 |
| Dryness | 40 (42.1) | 55 (36.7) | 1.26 (0.74-2.12) | 0.395 |
| Skin changes | 13 (13.7) | 19 (12.7) | 2.63 (1.23-5.63) | 0.818 |
| Pedal edema | 22 (23.2) | 31 (20.7) | 2.82 (1.51-5.26) | 0.644 |
| Ulcers | 69 (72.6) | 92 (61.3) | 1.67 (0.96-2.92) | 0.069 |
| Hair-fall | 15 (15.8) | 27 (18.0) | 0.85 (0.43-1.70) | 0.655 |
| Chest pain | 39 (41.1) | 66 (44.0) | 0.89 (0.53-1.49) | 0.650 |
| Joint pain | 36 (37.9) | 58 (38.7) | 0.97 (0.57-1.64) | 0.904 |
| GERD | 50 (52.6)* | 59 (39.3) | 1.71 (1.02-2.88) | 0.040 |
| Tuberculosis | 17 (17.9) | 31 (20.7) | 0.84 (0.43-1.61) | 0.594 |
| Hypertension | 31 (32.6) | 38 (25.3) | 1.43 (0.81-2.51) | 0.216 |
| Diabetes mellitus | 18 (18.9) | 21 (14.0) | 1.44 (0.72-2.86) | 0.302 |
| Visible Dust | 34 (35.8) | 55 (36.7) | 0.96 (0.56-1.64) | 0.889 |
| Pillow | 29 (30.5) | 35 (23.5) | 1.44 (0.81-2.57) | 0.223 |
| Biomass exposure | 43 (45.3) | 50 (33.6) | 1.65 (0.99-2.80) | 0.066 |
| Closed cooking area | 27 (28.4) | 35 (23.3) | 1.30 (0.73-2.34) | 0.372 |
| Change in house | 20 (21.1) | 26 (17.3) | 1.27 (0.66-2.43) | 0.468 |
| Bird exposure | 30 (31.6) | 59 (39.9) | 0.77 (0.45-1.33) | 0.191 |
| Caged/uncaged | 16 (16.8) | 28 (18.7) | 0.88 (0.45-1.73) | 0.717 |
| Substance abuse | 14 (14.7) | 30 (20.0) | 0.69 (0.35-1.38) | 0.296 |
| Current smoker | 6 (6.3) | 9 (6.0) | 1.06 (0.36-3.07) | 0.920 |
| Ex-smoker | 13 (13.7) | 18 (12.0) | 1.16 (0.54-2.50) | 0.699 |
Demographic features and symptoms of ILDs.
| IPF (n = 95) | NSIP (n = 37) | Sarcoidosis (n = 11) | CTD-ILD (n = 23) | |
|---|---|---|---|---|
| • Male | 31 (32.6) | (29.7) | 2 (18.2) | 5 (21.7) |
| • Female | 54 (67.4) | (70.1) | 9 (81.8) | 18 (78.3) |
| Age | 52.0±12.3 | 47.1±13.0 | 49.4±10.1 | 46.1±17.1 |
| • Dyspanea | 92 (96.8) | 36 (97.3) | 11 (100) | 20 (87) |
| • Cough | 85 (89.5) | 32 (86.5) | 9 (81.8) | 19 (82.6) |
| • Phlegm | 25 (26.3) | 10 (27.0) | 2 (18.2) | 3 (13.0) |
| • Postnasal drip | 19 (20.0) | 12 (32.4) | 1 (9.1) | 4 (17.4) |
| • Weight loss | 53 (55.8) | 20 (54.1) | 4 (36.4) | 11 (47.8) |
| • Dysphagea | 17 (17.9) | 4 (10.8) | 3 (27.3) | 5 (21.7) |
| • Dryness | 40 (42.1) | 12 (32.4) | 6 (54.5) | 12 (52.2) |
| • Skin changes | 13 (13.7) | 2 (5.4) | 1 (9.1) | 3 (13.0) |
| • Pedal edema | 22 (23.2) | 10 (27.0) | 1 (9.1) | 3 (13.0) |
| • Hematuria | 1 (1.1) | 0 (0) | 0 (0) | 0 (0) |
| • Ulcers | 26 (27.4) | 12 (32.4) | 4 (36.4) | 14 (60.8) |
| • Hair-fall | 15 (15.8) | 3 (8.1) | 1 (9.1) | 4 (17.4) |
| • Raynauds | 2 (2.1) | 0 (0) | 1 (9.1) | 4 (17.4) |
| • Chest pain | 39 (41.1) | 14 (37.8) | 5 (45.5) | 11 (47.8) |
| • Joint pain | 36 (37.9) | 13 (35.1) | 7 (63.6) | 8 (34.8) |
| • GERD | 50 (52.6) | 17 (45.9) | 4 (36.4) | 10 (43.5) |
Associated illnesses of ILDs.
| IPF (n = 95) | NSIP (n = 37) | Sarcoidosis (n = 11) | CTD-ILD (n = 23) | |
|---|---|---|---|---|
| Tuberculosis | 17 (17.9) | 10 (27.0) | 3 (27.3) | 4 (17.4) |
| Hypertension | 31 (32.6) | 14 (37.8) | 2 (18.2) | 6 (26.1) |
| Diabetes mellitus | 18 (18.6) | 8 (21.6) | 0 (0) | 3 (13.0) |
| Coronary Artery Disease | 7 (7.4) | 3 (8.1) | 0 (0) | 1 (4.3) |
| Congestive Cardiac Failure | 1 (1.1) | 0 (0) | 0 (0) | 0 (0) |
| Cerebro-Vascular Accident | 1 (1.1) | 1 (2.7) | 0 (0) | 1 (4.3) |
| Fits | 1 (1.1) | 0 (0) | 0 (0) | 1 (4.3) |
| Hepatitis | 1 (1.1) | 0 (0) | 1 (2.7) | 1 (4.3) |
| Kidney diseases | 3 (3.2) | 2 (5.4) | 1 (9.1) | 0 (0) |
| Pneumothorax | 0 (0) | 1 (2.7) | 0 (0) | 0 (0) |
| Pneumonia | 8 (8.4) | 2 (5.4) | 0 (0) | 3 (13.0) |
| Asthma | 4 (4.2) | 1 (2.7) | 0 (0) | 0 (0) |
| Pulmonary Hypertension | 5 (5.3) | 1 (2.7) | 0 (0) | 1 (4.3) |
| Obstructive Sleep Apnea | 2 (2.2) | 0 (0) | 0 (0) | 0 (0) |
| Rheumatological | 4 (4.2) | 3 (8.1) | 2 (18.2) | 5 (21.7) |